Domo signs strategic collaboration agreement with AWS for AI solutions
NEW YORK - INNOVATE Corp. (NYSE:VATE), a company with annual revenues of $1.07 billion and current market capitalization of approximately $78 million, announced Thursday that 99.41% of holders of its 8.5% Senior Secured Notes due 2026 have participated in its previously announced exchange offer, exceeding the 98% minimum threshold required. InvestingPro data shows the company faces significant financial challenges, with short-term obligations exceeding liquid assets.
According to the company, holders of $328.07 million of the $330 million outstanding notes tendered their securities by the July 30 early participation deadline. INNOVATE will exchange these notes for new 10.5% Senior Secured Notes due 2027. This restructuring comes as the company manages a total debt burden of $718.2 million, with a concerning current ratio of 0.44, according to InvestingPro analysis.
The company has extended the eligibility to receive the early exchange premium through the final August 13 expiration deadline. Participants will receive $1,020 in principal amount of new notes for each $1,000 of existing notes tendered, which includes a $20 early exchange premium.
INNOVATE also stated it will not make the scheduled August 1 interest payment on the existing notes. Instead, participating noteholders will receive an additional $52.50 in principal amount of new notes per $1,000 tendered, bringing the total consideration to $1,072.50 per $1,000 of existing notes.
The early settlement is expected to occur on August 4, with final settlement anticipated on August 15, subject to satisfaction of conditions.
The new notes will maintain substantially similar terms as the existing notes but will feature a later maturity date of February 1, 2027, a higher interest rate of 10.5%, and updated covenants. The first interest payment will be delivered as additional exchange consideration and the second payment will be made in kind.
The exchange offer remains conditional on the completion of several previously announced transactions, including convertible notes exchanges and various credit agreement extensions.
This information is based on a press release statement from INNOVATE Corp.
In other recent news, Innovate Corp reported a 13% decline in consolidated revenues for the first quarter of 2025, amounting to $274.2 million. The company also recorded a net loss of $24.8 million, or $1.89 per share. Despite these financial challenges, Innovate Corp announced FDA approval for a new medical device, marking a strategic advancement. Furthermore, S&P Global Ratings downgraded Innovate Corp’s long-term issuer credit rating to ’CCC-’ from ’CCC’, citing weak liquidity and a negative outlook. The rating agency expressed concerns about the company’s ability to meet financial commitments, noting the unsustainable capital structure. Additionally, Innovate Corp’s senior notes due 2026 were downgraded to ’CCC’ from ’CCC+’, though the recovery rating remains at ’2’. In another development, DBM Global Inc., a subsidiary of Innovate Corp, announced a $4.4 million cash dividend, with Innovate set to receive $4 million. S&P also downgraded Innovate Corp to ’CC’ due to a planned debt exchange, which they consider distressed.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.